GenMark Diagnostics

03/28/2022

Multiplex testing is valuable for early diagnosis of patients with respiratory infections and could aid with triage decisions for admission or discharge.

In the study, “Viral co-infections are associated with increased rates of hospitalization in those with influenza,”detection of viral co-infection in ED influenza A/B positive patients was associated with increased risk of hospital admission and can help guide specialised treatment options.

Access the study at https://onlinelibrary.wiley.com/doi/full/10.1111/irv.12967

To learn more about the GenMark ePlex RP2 Panel visit https://www.genmarkdx.com/panels/eplex-panels/respiratory-pathogen-panel/

03/14/2022

Join us next Monday, March 21, 2022, for our webinar to learn how rapid results from the Blood Culture Identification (BCID) panels have improved patient outcomes and reduced healthcare costs.

Correction to initial post: This webinar is not eligible for PACE CE credits.

02/23/2022

Throughout the COVID-19 pandemic, healthcare workers across many functions have struggled to keep up with managing patients with SARS-CoV-2 infection. While some elective surgeries were able to be placed on hold, others involving bacteremia and fungemia were not due to the severity of these infections.

Join our live webinar to learn how Dr. Boyle and her team have implemented the GenMark Diagnostics BCID panels, and performed studies to show how they have both reduced hospital costs and patients length of stay, as well as improved patient outcomes and healthcare worker time savings and safety during the COVID-19 pandemic.

Registration link: https://xtalks.com/webinars/the-benefits-of-rapid-blood-culture-identification-during-the-covid-19-pandemic/

12/30/2021

Did you know that we have a YouTube channel? Check it out and subscribe so that you can see our latest videos!

https://www.youtube.com/channel/UCyCwDJTWOcR4f_836OQjaRA

12/07/2021

Although overall activity remains low, detection of influenza A H3N2 has been on the rise, especially in young adults in college settings. The CDC is reminding clinicians to consider testing for influenza and SARS-CoV-2 and note that molecular tests offer the most accurate results, especially for hospitalized patients with suspected influenza.

Learn more: https://emergency.cdc.gov/han/2021/han00458.asp

The ePlex RP2 Panel offers detection of Influenza, SARS-Cov-2 and more than 20 of the most common respiratory pathogens, enabling clinicians to quickly identify what is making their patients sick.

12/06/2021

A new SARS-CoV-2 variant first reported in South Africa and Botswana, B.1.1.529, has now been designated by the WHO as a Variant of Concern (VOC) and assigned the Greek name Omicron. The number of mutations in this variant is causing concern, and over 30 mutations have been reported in the spike protein region alone. A virologist in the UK noted this is the most heavily mutated version of the virus yet identified.

Click to learn more about the priliminary analysis of the Omicron variant detection on the ePlex RP2 Panel: https://genmarkdx.com/detection-of-omicron-variant-on-the-eplex-rp2-panel/

11/10/2021

Using the ePlex RP2 Panel can quickly identify the cause of illness. Detection of a viral pathogen can help reduce the unnecessary use of antibiotics.

Read article: https://www.mlo-online.com/disease/flu/article/21242230/frontline-testing-with-multiplex-respiratory-panels

11/09/2021

Sepsis is a condition that can be caused by bacteria, fungi or viruses in the blood and is the result of the body’s response to infection. Rapid detection of sepsis or bloodstream infections was shown to reduce the mean hospital length of stay by 2.5 days.

The ePlex BCID Panels can identify >10% more of the organisms that cause sepsis compared with other rapid molecular diagnostic tests, aiding in earlier diagnosis for more patients.

To learn more, visit: https://genmarkdx.com/panels/eplex-panels/bcid-panels/

11/08/2021

Dr. Yvan Casper, a clinical microbiologist from Centre Hospitalier Universitaire Grenoble Alpes (CHUGA), shares the results of a retrospective analysis assessing the clinical impact of the ePlex BCID Panels.

Learn how the ePlex BCID Panels can deliver value for your patients and hospital teams.

Register now for our PACE-accredited webinar at gnmk.info/CHUGA-webinar.

10/15/2021

Testing for blood culture contamination differentiates between bloodstream infection and an external contamination that could have occured at various stages of the testing process, from sample collection to sample analysis. Failure to recognize blood culture contamination can result in misdiagnosis, inappropriate antibiotic use, and extended hospital stays.

                          Bloodstream Infections/Sepsis Sepsis is a condition that can be caused by bacteria, fungi or viruses in the blood and is the result of the body’s response to infection. Approximately 30-35% of cases of severe sepsis are fatal, with mortality exceeding that

10/13/2021

A new GenMark customer study found that patients co-infected with influenza B and another respiratory pathogen were more likely to have severe disease. Rhinovirus/enterovirus, parainfluenza virus and adenovirus were the most frequent co-infections. Using a multiplex test, like the ePlex RP2 Panel, to detect the presence of more than one pathogen can help guide patient care decisions and identify which patients may be at higher risk for complications.

Background Influenza B accounts for approximately one fourth of the seasonal influenza burden. However, research on the importance of influenza B has received less attention compared to influenza A....

10/08/2021

While many respiratory viruses decreased in prevalence during the pandemic due to social distancing and other preventive measures, rhinovirus and enterovirus continued to circulate at historical rates, suggesting something is different with these viruses. Identifying rhinovirus/enterovirus and ruling out flu or SARS-CoV-2 can improve patient and bed management by enabling doctors to safely manage those patients at home.

Finding out why rhinovirus and enterovirus have persisted during the pandemic can help inform future prevention recommendations, experts say.